FLEXIBLE, ROBUST, &AUTOMATED MICROARRAY ANALYSIS

Information

  • Research Project
  • 6094201
  • ApplicationId
    6094201
  • Core Project Number
    N43CM097104
  • Full Project Number
    N43CM097104-001
  • Serial Number
    97104
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/1/1999 - 25 years ago
  • Project End Date
    -
  • Program Officer Name
  • Budget Start Date
    7/1/1999 - 25 years ago
  • Budget End Date
    1/31/2000 - 24 years ago
  • Fiscal Year
    1999
  • Support Year
  • Suffix
  • Award Notice Date
    -
Organizations

FLEXIBLE, ROBUST, &AUTOMATED MICROARRAY ANALYSIS

Without good analytical tools, interpreting microarray data will remain a slow and arduous process. We will develop microarray analysis software to accelerate discovery of causal or diagnostic relationships between gene expression and genetic, environmental, pathological, and developmental conditions. This software will integrate user-configurable analysis tools, multiple visualization methods, and direct interactions with external databases, to help scientists interpret microarray data. These tools will be provided in a readily-extensible architecture so data from other gene expression detection techniques and newly discovered analytical methods can be easily incorporated. Finally, this software will help automate repetitive analytical steps, thus speeding the transition from data to hypotheses. This software will facilitate any research or diagnosis that employs microarrays, including clinical studies, drug discovery, and basic research. During Phase 1, we will design and implement software prototypes that fulfills these functional requirements: 1. Microarray analysis software must have a robust and extensible mathematical analysis architecture. Our architecture will allow users to create their own analytical methods as well as employ those that come packaged with the software. 2. It must have a robust and extensible visualization architecture. The user must be presented with an intuitive and informative interface for selecting from the available microarray experiments, and he should be able to group experiments for subsequent analyses and to share with collaborators. 3. It must provide user-configurable tools to automate data curation and analysis.

IC Name
DIVISION OF CANCER TREATMENT
  • Activity
    N43
  • Administering IC
    CM
  • Application Type
    3
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
  • Study Section Name
  • Organization Name
    GENOMICA CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    BOULDER
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    80303
  • Organization District
    UNITED STATES